Nurexone Biologic Inc
F:J90
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurexone Biologic Inc
F:J90
|
CA |
|
AES Corp
NYSE:AES
|
US |
|
Sunoco LP
NYSE:SUN
|
US |
|
Atmos Energy Corp
NYSE:ATO
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
Bank of the Philippine Islands
OTC:BPHLY
|
PH |
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
D
|
Dr Martens PLC
OTC:DOCMF
|
UK |
|
B
|
Bombardier Inc
OTC:BDRBF
|
CA |
|
W
|
Walt Disney Co
XMUN:WDP
|
US |
|
X
|
Xero Ltd
F:0XE
|
NZ |
|
A
|
American Express Co
F:AEC1
|
US |
|
Polyplex Corp Ltd
NSE:POLYPLEX
|
IN |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
A
|
Altea Green Power SpA
MIL:AGP
|
IT |
Bankruptcy Probability
Nurexone Biologic Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nurexone Biologic Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Nurexone Biologic Inc
F:J90
|
26m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
275.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
100.9B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
66.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cerebras Systems Inc.
NASDAQ:CBRS
|
59B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
50.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
36.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nurexone Biologic Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nurexone Biologic Inc has total debt of 70k USD. This includes both short-term (0 USD) and long-term (70k USD) debt.
You can find a full breakdown on its Balance Sheet.
